Aptevo Therapeutics Inc(NASDAQ:APVO) 
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinic...
Website: http://aptevotherapeutics.com
Founded: 2016
Full Time Employees: 80
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 37.20
H 38.60
L 24.60
C 29.80
V 4,444,578
10EMA 29.80
20EMA 29.80
60EMA 29.80
120EMA 29.80
250EMA 29.80